Xingkun Xu

Xingkun Xu

Auto-generated profile, based on publicly available information

Xingkun Xu

Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Digital Medicine Innovation Center, Shanghai National Center for Translational Medicine, Lifecycle Health Management Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Rui Jin 2nd Road, Shanghai 200025, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2022
Verified
Book Chapter
Closed access
PDF file
JJJiazhen Ji
Jiazhen Ji
HWHuan Wang
Huan Wang
YHYuge Huang
Yuge Huang
JWJiaxiang Wu
Jiaxiang Wu
XXXingkun Xu
Xingkun Xu
RJRongrong Ji
Rongrong Ji

22 January 2025 in Expert Systems with Applications
Verified
Journal Article
Open access
QXQinwei Xu
Qinwei Xu
XXXingkun Xu
Xingkun Xu
CZChenyi Zhou
Chenyi Zhou
ZLZuozhu Liu
Zuozhu Liu
FHFeiyue Huang
Feiyue Huang
WHWeiguo Hu
Weiguo Hu

1 November 2025 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
SLShaoxin Li
Shaoxin Li
CZCan Zheng
Can Zheng
JWJiaxiang Wu
Jiaxiang Wu
QXQinwei Xu
Qinwei Xu
XXXingkun Xu
Xingkun Xu
FHFeiyue Huang
Feiyue Huang
Clinical coding translates medical information from Electronic Health Records (EHRs) into structured codes such as ICD-10, which are essential for healthcare applications. Advances in deep learning and natural language processing have enabled automatic ICD coding models to achieve notable accuracy metrics on in-domain datasets when adequately trained. However, the scarcity of clinical medical texts and the variability across different datasets pose significant challenges, making it difficult for current state-of-the-art models to ensure robust generalization performance across diverse data distributions. Recent advances in Large Language Models (LLMs), such as GPT-4o, have shown great generalization capabilities across general domains and potential in medical information processing tasks. However, their performance in generating clinical codes remains suboptimal. In this study, we propose a novel ICD coding paradigm based on code verification to leverage the capabilities of LLMs. Instead of directly generating accurate codes from a vast code space, we simplify the task by verifying the code assignment from a given candidate set. Through extensive experiments, we demonstrate that LLMs function more effectively as code verifiers rather than code generators, with GPT-4o achieving the best performance on the CodiEsp dataset under zero-shot settings. Furthermore, our results indicate that LLM-based systems can perform on par with state-of-the-art clinical coding systems while offering superior generalizability across institutions, languages, and ICD versions.

9 July 2026 in European Heart Journal
Verified
Journal Article
Closed access
QCQiuyu Cao
Qiuyu Cao
XXXingkun Xu
Xingkun Xu
HLHong Lin
Hong Lin
YYYue Yin
Yue Yin
SWShengli Wu
Shengli Wu
JLJieli Lu
Jieli Lu
Traditional Cox proportional hazards models show suboptimal performance for cardiovascular disease (CVD) risk prediction in Chinese populations. Transformer-based deep learning models have demonstrated promise in clinical risk prediction. In this study, sex-specific transformer-based models (China-AIHeart) for 10-year CVD risk prediction among Chinese adults were developed and validated. The derivation cohort included 156 790 participants [34.6% men; mean [SD] age, 56.7 [8.9] years) without CVD from the China Cardiometabolic Disease and Cancer Cohort. External validation was conducted in two independent Chinese cohorts (Xinjiang and CHARLS). Transformer-based time-to-event prediction models were developed, including a full model (22 predictors) and a simplified model (15 predictors). Performance was compared with Cox models using identical predictors and established risk scores (China-PAR, PREVENT-ASCVD, and SCORE2 Asia-Pacific equations). China-AIHeart demonstrated good discrimination (C-statistic [95% confidence interval, CI]: .767 [.754-.779] in men; .780 [.769-.791] in women), calibration (calibration χ2: 14.806 in men; 9.326 in women; Brier score: .104 in men; .077 in women), and net clinical benefit in predicting CVD risk. Predicted event rates closely matched observed risks across strata. Compared with Cox models with identical predictors, China-AIHeart showed improved discrimination (ΔC-statistic [95% CI]: .027 [.025-.028] in men; .031 [.029-.033] in women) and reclassification (net reclassification index [95% CI]: .478 [.466-.492] in men; .560 [.551-.572] in women), and outperformed China-PAR, PREVENT-ASCVD, and SCORE2 Asia-Pacific equations. External validation demonstrated robust performance, with C-statistics of .781/.825 (men/women) and .748/.820 for the full and simplified models in the Xinjiang cohort, and .740/.771 for the simplified model in the CHARLS cohort. The transformer-based China-AIHeart models predicted 10-year CVD risk and outperformed traditional Cox-based approaches, providing a practical tool for risk stratification in Chinese adults.

21 March 2026 in Pattern Recognition
Verified
Journal Article
Open access
RWRui Wang
Rui Wang
FTFan Tang
Fan Tang
FHFeiyue Huang
Feiyue Huang
SLShaoxin Li
Shaoxin Li
XXXinkun Xu
Xinkun Xu
WDWeiming Dong
Weiming Dong

21 May 2026 in Knowledge-Based Systems
Verified
Journal Article
Closed access
YMYuxiang Meng
Yuxiang Meng
DZDengwen Zhou
Dengwen Zhou
SLShaoxin Li
Shaoxin Li
FHFeiyue Huang
Feiyue Huang
XXXingkun Xu
Xingkun Xu
FTFan Tang
Fan Tang